Similar Search Results

Does waiting times decrease or increase operational costs in short and long-term? : evidence from Portuguese public hospitals

Madeira, André; Moutinho, Victor Ferreira; Fuinhas, … - In: The European journal of health economics 22 (2021) 8, pp. 1195-1216

Persistent link: https://www.econbiz.de/10012665561

Paying more to wait less: estimating the cost of reducing Ireland's public hospital waiting lists

Brick, Aoife; Keegan, Conor - 2020

Larger and longer waiting lists for public hospital appointments and treatment have been a significant challenge in Irish healthcare for decades. The issue has been further exacerbated by COVID-19 in 2020 with the cancellation of elective activity in public hospitals for several months. The aim...

Persistent link: https://www.econbiz.de/10012389965

Chapter 23 Waiting lists and medical treatment: Analysis and policies

Cullis, John G.; Jones, Philip R.; Propper, Carol - In: Handbook of health economics : volume 1, part B, (pp. 1201-1249). 2000

A number of health care systems use waiting time as a rationing device for access to inpatient care. However, a considerable amount of research has focussed in particular on the UK's National Health Service and its perceived problem of waiting “lists”. In this chapter a theoretical...

Persistent link: https://www.econbiz.de/10014024182

The economic evaluation of screening for breast cancer : a tentative methodology

Gravelle, Hugh - 1976

Persistent link: https://www.econbiz.de/10000739206

Use of POHEM to estimate direct medical costs of current practice and new treatments associated with lung cancer in Canada

Houle, Christian (contributor) - 1997

Persistent link: https://www.econbiz.de/10000960056

Killing by lung cancer or by diabetes? : the trade-off between smoking and obesity

Todeschini, Federico; Jiménez-Martín, Sergi; Labeaga, … - 2010

Persistent link: https://www.econbiz.de/10008663495

Patients’ preferences : a discrete-choice experiment for treatment of non-small-cell lung cancer

Mühlbacher, Axel; Bethge, Susanne - In: The European journal of health economics : HEPAC ; … 16 (2015) 6, pp. 657-670

Persistent link: https://www.econbiz.de/10011299251

Damm, Kathrin; Roeske, Nicole; Jacob, Christian - In: Health economics review 3 (2013) 15, pp. 1-10

Background: Lung cancer is one of the leading causes of cancer deaths. Treatment goals are the relief of symptoms and … instruments applied in lung cancer patients under drug therapy. Methods: We conducted a systematic literature review at the … different measurement instruments were identified, including 5 generic, 5 cancer-specific, 4 lung cancer-specific and 3 symptom …

Persistent link: https://www.econbiz.de/10009755973

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer : a systematic review and critique

Parkinson, Bonny; Pearson, Sallie-Anne; Viney, Rosalie - In: The European journal of health economics : HEPAC ; … 15 (2014) 1, pp. 93-112

Persistent link: https://www.econbiz.de/10010235891

Health state utilities for skeletal-related events secondary to bone metastases

Matza, Louis S.; Chung, Karen; Van Brunt, Kate; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 1, pp. 7-18

Persistent link: https://www.econbiz.de/10010235900